Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.
This report contains market size and forecasts of Acute Ischemic Stroke Drugs in Global, including the following market information:
Global Acute Ischemic Stroke Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acute Ischemic Stroke Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acute Ischemic Stroke Drugs include Sanofi, Biogen, Bayer, Pfizer, Roche, Boehringer Ingelheim, Daiichi Sankyo, Bristol-Myers Squibb and Johnson＆Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Ischemic Stroke Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Ischemic Stroke Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acute Ischemic Stroke Drugs Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Other
Global Acute Ischemic Stroke Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acute Ischemic Stroke Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Others
Global Acute Ischemic Stroke Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acute Ischemic Stroke Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Ischemic Stroke Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acute Ischemic Stroke Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Biogen
Bayer
Pfizer
Roche
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb
Johnson＆Johnson
AstraZeneca
ZZ Biotech
NoNO Inc
Athersys
SanBio